34 MAPLE ST, MILFORD, MA
Reports Second Quarter 2025 Financial Results
News, Reorganization Plan
Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing, Investor Presentation
Material Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Submission of Matters to a Vote of Security Holders
Reports First Quarter 2025 Financial Results
Annual Report to Security Holders
Investor Presentation
Q2
Q1
FY 2023
Q3
Prospectus Filed Pursuant to Rule 425
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Annual Report of Employee Stock Purchase
Specialized Disclosure Report